"Early-stage companies received $956 million dollars in new investment during Q2, up 43% from $668 million the previous quarter. That's the first significant increase in early-stage investment since the fourth quarter of 1999."
Biotech sales forces are small, elite, experienced, and capable of running a total business. Many start right after college with major pharmaceutical companies, which hire thousands of salespeople annually.
There's plenty of scholarship out there, and pretty much all of it suggests that micromanaging knowledge workers--let alone whacking them over the head, pinching them on the *ss, and making them feel like dirt--is a bad idea.